Free Trial

BriaCell Therapeutics (BCT) News Today

BriaCell Therapeutics logo
C$10.69 +0.59 (+5.84%)
As of 08/29/2025 03:53 PM Eastern

Why Is BriaCell Therapeutics Up Today?

BriaCell Therapeutics Corp. (TSE:BCT) shares climbed today after HC Wainwright issued a raft of upward revisions to its earnings forecasts across several quarters and fiscal years, narrowing projected losses and forecasting a move into profitability by FY 2030.

  • Positive Sentiment: Q4 2025 EPS estimate raised to ($10.39) from ($19.20). Free Report
  • Positive Sentiment: FY 2025 EPS estimate improved to ($2.58) from ($36.30). Free Report
  • Positive Sentiment: FY 2026 EPS estimate lifted to ($9.83) from ($24.40). Free Report
  • Positive Sentiment: FY 2027 EPS estimate narrowed to ($2.92) from ($19.90). Free Report
  • Positive Sentiment: FY 2028 EPS estimate improved to ($1.34) from ($11.70). Free Report
  • Positive Sentiment: FY 2029 EPS estimate lifted to ($0.64) from ($4.60). Free Report
  • Neutral Sentiment: Q1 2026 EPS forecast set at ($2.82). Free Report
  • Neutral Sentiment: Q2 2026 EPS forecast set at ($4.15). Free Report
  • Neutral Sentiment: Q3 2026 EPS forecast set at ($2.35). Free Report
  • Neutral Sentiment: Q4 2026 EPS forecast set at ($1.79). Free Report
  • Neutral Sentiment: FY 2030 EPS projected at $0.50, marking the first positive profitability forecast. Free Report
Posted 9h agoAI Generated. May Contain Errors.

BCT Latest News

Get BriaCell Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BCT and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BCT Media Mentions By Week

BCT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BCT
News Sentiment

0.61

1.05

Average
Medical
News Sentiment

BCT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BCT Articles
This Week

12

0

BCT Articles
Average Week

Get the Latest News and Ratings for BCT and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for BriaCell Therapeutics and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (TSE:BCT) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners